Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy

Por Robuccio, Anna, Ssentongo, Paddy, Sather, Michael D., Claxton, David F., Gilliam, Frank G.
Publicado no Epilepsy Behav Case Rep (2015)

Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model

Por Liu, Qiang, Chen, Longgui, Atkinson, Jennifer M, Claxton, David F, Wang, Hong-Gang
Publicado no Cell Death Dis (2016)

Orbital Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder in an Apparently Immunocompetent Woman

Por Abendroth, Michael D., Bayerl, Michael G., Wilkinson, Michael J., Claxton, David F., Specht, Charles S.
Publicado no Ocul Oncol Pathol (2017)

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: Evidence for multiple critical loci

Por Liang, Hong, Fairman, Jeff, Claxton, David F., Nowell, Peter C., Green, Eric D., Nagarajan, Lalitha
Publicado em 1998

A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects

Por Keasey, Nikki, Herse, Zachary, Chang, Stella, Liggitt, Denny H, Lay, Marla, Fairman, Jeffery, Claxton, David F
Publicado em 2010

STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia

Por Doshi, Ushma A, Shaw, Jeremy, Fox, Todd E, Claxton, David F, Loughran, Thomas P, Kester, Mark
Publicado no Signal Transduct Target Ther (2017)

Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia: A retrospective cohort study of 73 patients

Por Stefanski, Michael, Jamis-Dow, Carlos, Bayerl, Michael, Desai, Ruchi J., Claxton, David F., Van de Louw, Andry
Publicado no Medicine (Baltimore) (2016)

Impact of Ruxolitinib on Myelofibrosis Patients Post Allogeneic Stem Cell Transplant---A Pilot Study

Por Pu, Jeffrey J., Poulose, Joyson, Malysz, Jozef, Zhu, Junjia, Fanburg-Smith, Julie C., Claxton, David F., Bayerl, Michael G.
Publicado no Br J Haematol (2019)

Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability

Por Salzberg, Anna C., Harris-Becker, Abigail, Popova, Evgenya Y., Keasey, Nikki, Loughran, Thomas P., Claxton, David F., Grigoryev, Sergei A.
Publicado no PLoS One (2017)

Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia

Por O'Brien, Susan M., Claxton, David F., Crump, Michael, Faderl, Stefan, Kipps, Thomas, Keating, Michael J., Viallet, Jean, Cheson, Bruce D.
Publicado no Blood (2009)

Downregulation of CD73 associates with T cell exhaustion in AML patients

Por Kong, Yaxian, Jia, Bei, Zhao, Chenchen, Claxton, David F., Sharma, Arati, Annageldiyev, Charyguly, Fotos, Joseph S., Zeng, Hui, Paulson, Robert F., Prabhu, K. Sandeep, Zheng, Hong
Publicado no J Hematol Oncol (2019)

Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia – Impact on enzyme activity and response to cytotoxics

Por Morad, Samy A. F., Tan, Su-Fern, Feith, David J., Kester, Mark, Claxton, David F., Loughran, Thomas P., Barth, Brian M., Fox, Todd E., Cabot, Myles C.
Publicado no Biochim Biophys Acta (2015)

Combinatorial Efficacy of Quercitin and Nanoliposomal Ceramide for Acute Myeloid Leukemia

Por McGill, Colin M., Brown, Timothy J., Fisher, Lindsey N., Gustafson, Sally J., Dunlap, Kriya L., Beck, Adam J., Toran, Paul T., Claxton, David F., Barth, Brian M.
Publicado no Int J Biopharm Sci (2018)

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

Por Jia, Bei, Wang, Liru, Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Rizvi, Syed, Shike, Hiroko, Bayerl, Michael, Schell, Todd D., Hohl, Raymond J., Zheng, Hong
Publicado no Blood Cancer J (2018)

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

Por Wang, Liru, Jia, Bei, Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Naik, Seema, Khawaja, Muhammad R., Sivik, Jeff, Han, Junyan, Hohl, Raymond J., Zheng, Hong
Publicado no Oncoimmunology (2018)

Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group...

Por Kempin, Sanford, Sun, Zhuoxin, Kay, Neil E., Paietta, Elisabeth M., Mazza, Joseph J., Ketterling, Rhett P., Frankfurt, Olga, Claxton, David F., Saltzman, Joel N., Srkalovic, Gordan, Callander, Natalie S., Gross, Gerald, Tallman, Martin S
Publicado no Acta Haematol (2019)

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia

Por Zhu, Liuluan, Kong, Yaxian, Zhang, Jianhong, Claxton, David F., Ehmann, W. Christopher, Rybka, Witold B., Palmisiano, Neil D., Wang, Ming, Jia, Bei, Bayerl, Michael, Schell, Todd D., Hohl, Raymond J., Zeng, Hui, Zheng, Hong
Publicado no J Hematol Oncol (2017)

Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia

Por McGill, Colin M., Brown, Timothy J., Cheng, Yuan-Yin, Fisher, Lindsey N., Shanmugavelandy, Sriram S., Gustafson, Sally J., Dunlap, Kriya L., Lila, Mary Ann, Kester, Mark, Toran, Paul T., Claxton, David F., Barth, Brian M.
Publicado no Int J Biopharm Sci (2018)

Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML

Por Zhao, Chenchen, Jia, Bei, Wang, Ming, Schell, Todd D., Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Naik, Seema, Songdej, Natthapol, Sivik, Jeff M., Hohl, Raymond J., Zeng, Hui, Zheng, Hong
Publicado no Br J Haematol (2019)

Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity

Por Kokolus, Kathleen M., Haley, Jeremy S., Koubek, Emily J., Gowda, Raghavendra, Dinavahi, Saketh S., Sharma, Arati, Claxton, David F., Helm, Klaus F., Drabick, Joseph J., Robertson, Gavin P., Neighbors, Jeffrey D., Hohl, Raymond J., Schell, Todd D.
Publicado no Oncoimmunology (2018)